Related references
Note: Only part of the references are listed.Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C
Carlo Fabris et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver
Scott L. Friedman
PHYSIOLOGICAL REVIEWS (2008)
Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality
O. A. Gressner et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis
Sharon L. Lederer et al.
VIROLOGY JOURNAL (2006)
Microfibril-associated protein 4 binds to surfactant protein a (SP-A) and colocalizes with SP-A in the extracellular matrix of the lung
A. Schlosser et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Aβ region of amyloid precursor protein
HF Poon et al.
MOLECULAR BRAIN RESEARCH (2005)
Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma
B Sitek et al.
PROTEOMICS (2005)
FibroTest-FibroSURE(TM): towards a universal biomarker of liver fibrosis?
T Poynard et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2005)
CSRP2, TIMP-1, and SM22α promoter fragments direct hepatic stellate cell-specific transgene expression in vitro, but not in vivo
J Herrmann et al.
LIVER INTERNATIONAL (2004)
A peptide preconcentration approach for nano-high-performance liquid chromatography to diminish memory effects
H Schaefer et al.
PROTEOMICS (2004)
Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus
Y Yokoyama et al.
PROTEOMICS (2004)
Serum markers detect the presence of liver fibrosis: A cohort study
WMC Rosenberg et al.
GASTROENTEROLOGY (2004)
Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications
Scott L. Friedman
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2004)
Sampling variability of liver fibrosis in chronic hepatitis C
P Bedossa et al.
HEPATOLOGY (2003)
Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin
T Poynard et al.
HEPATOLOGY (2003)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Characterization of a stellate cell activation-associated protein (STAP) with peroxidase activity found in rat hepatic stellate cells
N Kawada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Changes in histological lesions and serum fibrogenesis markers in chronic hepatitis C patients non-responders to interferon alpha
V Leroy et al.
JOURNAL OF HEPATOLOGY (2001)
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C
T Poynard et al.
JOURNAL OF HEPATOLOGY (2001)
Epidemiology of hepatitis C: Geographic differences and temporal trends
A Wasley et al.
SEMINARS IN LIVER DISEASE (2000)
Share Paper
